CLINICAL_TRIALS
trial_result
· 2021-03-26
Clinical Trial Update: A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Summary
Phase 3 trial comparing MB02 to Avastin in stage IIIB/IV non-squamous non-small cell lung cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: mAbxience Research S.L. | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-03-26